Literature DB >> 27726520

Multimodal Imaging in Ocular Tuberculosis.

Aniruddha Agarwal1,2, Sarakshi Mahajan1, Moncef Khairallah3, Padmamalini Mahendradas4, Amod Gupta1, Vishali Gupta1.   

Abstract

Intraocular tuberculosis presents a diagnostic challenge because of its protean clinical manifestations. Thus, it becomes imperative to distinguish chorioretinal inflammation due to tuberculosis from other infectious as well as non-infectious posterior uveitis since the clinical manifestations of these entities may be quite similar. With advancing technology, a number of novel imaging modalities are available today that enable in vivo near-histologic assessment of the chorioretinal tissue, greatly aiding the clinician in establishing a diagnosis and monitoring the therapeutic response of tubercular lesions. Techniques such as ultra-wide field fundus photography, fluorescein and indocyanine green angiography, optical coherence tomography and most recently, optical coherence tomography angiography, provide valuable information that helps in advancing our knowledge regarding the pathogenesis and natural history of the disease. The index review describes how these techniques supplement each other, and highlights the relevance of multimodal imaging in the management of intraocular tuberculosis.

Entities:  

Keywords:  Fundus autofluorescence; fundus fluorescein angiography; indocyanine green angiography; multifocal serpiginoid choroiditis; optical coherence tomography

Mesh:

Substances:

Year:  2016        PMID: 27726520     DOI: 10.1080/09273948.2016.1231332

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  14 in total

1.  Repeatability of Optical Coherence Tomography Angiography in Uveitic Eyes.

Authors:  Sonny Caplash; Shilpa Kodati; Shuk Kei Cheng; Marib Akanda; Susan Vitale; Ian Thompson; Sapna Gangaputra; H Nida Sen
Journal:  Transl Vis Sci Technol       Date:  2019-11-15       Impact factor: 3.283

Review 2.  Infectious uveitis: an Asian perspective.

Authors:  Aniruddha Agarwal; Kanika Aggarwal; Vishali Gupta
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

3.  Multimodal imaging of choroidal tubercles.

Authors:  T Lekha; Ramaraju Karthikeyan
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

Review 4.  Optical coherence tomography angiography (OCTA) as a new diagnostic tool in uveitis.

Authors:  Vita L S Dingerkus; Marion R Munk; Max P Brinkmann; Florentina J Freiberg; Florian M A Heussen; Stephan Kinzl; Sandra Lortz; Selim Orgül; Matthias Becker
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-05-28

5.  Commentary: Presumed tubercular posterior scleritis - What is our understanding so far?

Authors:  Aniruddha Agarwal
Journal:  Indian J Ophthalmol       Date:  2019-08       Impact factor: 1.848

Review 6.  Optical coherence tomography angiography in uveitis.

Authors:  Paris Tranos; Evdoxia-Maria Karasavvidou; Olga Gkorou; Carlos Pavesio
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-12-23

Review 7.  Ocular tuberculosis: Where are we today?

Authors:  Ilaria Testi; Rupesh Agrawal; Salil Mehta; Soumvaya Basu; Quan Nguyen; Carlos Pavesio; Vishali Gupta
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

Review 8.  Imaging in tuberculosis-associated uveitis.

Authors:  Reema Bansal; Soumyava Basu; Amod Gupta; Narsing Rao; Alessandro Invernizzi; Michal Kramer
Journal:  Indian J Ophthalmol       Date:  2017-04       Impact factor: 1.848

9.  Concurrent tuberculous chorioretinitis with choroidal neovascularization and tuberculous meningitis: a case report.

Authors:  Yan-Kun Zhang; Hong-Yi Fu; Yan Guan; Yu-Jing Li; Hong-Zhong Bai
Journal:  BMC Ophthalmol       Date:  2020-06-12       Impact factor: 2.209

10.  Semi-automated quantitative analysis of the middle limiting membrane in tubercular serpiginous-like choroiditis using swept-source optical coherence tomography.

Authors:  Aniruddha Agarwal; Gagan Kalra; Rupesh Agrawal; Reema Bansal; Vishali Gupta
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.